35.38MMarket Cap-298P/E (TTM)
0.590High0.479Low787.85KVolume0.580Open0.570Pre Close411.04KTurnover1.51%Turnover RatioLossP/E (Static)72.19MShares2.40352wk High2.20P/B25.65MFloat Cap0.29652wk Low--Dividend TTM52.33MShs Float16.410Historical High--Div YieldTTM19.46%Amplitude0.296Historical Low0.521Avg Price1Lot Size
Beyond Air Stock Forum
Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Beyond Cancer, , a clinical stage biotechnology company, has been selected to present two poster presentations at the upcoming Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024. The event is scheduled for November 6-10 at the George R. Brown Convention Center in Houston, Texas. The ...
5 MINUTES AGO, 7:30 AM EDT
VIA GLOBENEWSWIRE
Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules
– Financing strengthens balance sheet and is expected to provide sufficient cash runway through June 2026 –
– Retiring $17.5 million in Avenue Capital debt, aided by $11.5 million in new debt from insider-led group; eliminates $12 million in scheduled debt payments through June 2026 –
– Avenue Capital, current insiders, and select group of healthcare-focuse...
No comment yet